ACF Investors

Type

Venture Capital

Status

Active

Location

London, United Kingdom

Total investments

144

Average round size

3M

Portfolio companies

101

Rounds per year

11.08

Lead investments

18

Follow on index

0.30

Exits

15

Stages of investment
SeedPrivate EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyE-CommerceSoftwareFinancial ServicesFinTechFood and BeverageHealth CareSaaSManufacturingMedical Device

Summary

Angel CoFund is the famous VC, which was founded in 2011. The venture was found in Europe in United Kingdom. The leading representative office of defined VC is situated in the Sheffield.

When the investment is from Angel CoFund the average startup value is 1-5 millions dollars. Considering the real fund results, this VC is 1 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 7-12 investment rounds annually. The important activity for fund was in 2013. The increased amount of exits for fund were in 2019. Comparing to the other companies, this Angel CoFund performs on 20 percentage points less the average number of lead investments. Deals in the range of 1 - 5 millions dollars are the general things for fund.

This organization was formed by George Whitehead. We also calculated 3 valuable employees in our database.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Angel CoFund, startups are often financed by MMC Ventures, Northstar Ventures, Newable Private Investing. The meaningful sponsors for the fund in investment in the same round are MMC Ventures, Business Growth Fund, Wren Capital. In the next rounds fund is usually obtained by MMC Ventures, Unilever Ventures, SyndicateRoom.

Among the most popular portfolio startups of the fund, we may highlight Sky Medical Technology, Creo Medical, Gousto. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Software, Health Care. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low.

Show more

Investor highlights

Industry generalist
Yes
Industry focus
GeneralistAI/Big DataB2B/EnterpriseCloud/InfrastructureConsumer/Retail Show 6 more
Stage focus
Series ASeries B
Geo focus
United Kingdom
Check size
249K — 1M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
GBP 30000000
Fund raised date
2021-01-26

Analytics

Total investments
144
Lead investments
18
Exits
15
Rounds per year
11.08
Follow on index
0.30
Investments by industry
  • Software (29)
  • Biotechnology (26)
  • Health Care (23)
  • Manufacturing (18)
  • Food and Beverage (14)
  • Show 167 more
Investments by region
  • United Kingdom (140)
  • Germany (1)
  • United States (3)
Peak activity year
2013
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
11
Avg. valuation at time of investment
23M
Group Appearance index
0.78
Avg. company exit year
9
Avg. multiplicator
2.69
Strategy success index
0.20

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Adapttech 06 Apr 2022 Biotechnology, Medical Device Early Stage Venture 3M England, Birmingham, United Kingdom
Spotta 15 Dec 2023 Hospitality, Housekeeping Service Early Stage Venture 4M England, Cambridge, United Kingdom

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.